跳至主要内容
临床试验/NCT03374163
NCT03374163已完成2 期

Effect Of Intravenous IntralipidTherapyon Pregnancy Outcome in Women With History of Recurrent Implantation Failure Undergoing Intracytoplasmic Sperm Injection-Embryo Transfer Cycle: A Randomized Controlled Trial

King Fahad Medical City0 个研究点目标入组 142 人开始时间: 2015年1月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
入组人数
142
主要终点
pregnancy rate

研究概览

简要总结

To evaluate the effect ofempiricintralipidinfusion therapy on pregnancy outcomes in patient withunexplained recurrentimplantation failure (RIF) undergoIntracytoplasmic sperm injection (ICSI).

详细描述

the aim to evaluate the effect ofempiricintralipidinfusion therapy on pregnancy outcomes in patient withunexplained recurrentimplantation failure (RIF) undergoIntracytoplasmic sperm injection (ICSI).

A total of 142 patients with history of unexplained RIF3 or more cycles were included in the study. Patient were randomized into two groups, study group (n=71) and control group (n=71). The study groupreceivedintralipid 20%infusionon the day of embryo transfer (ET) and a second dose on the day of pregnancy test. The control group underwent ET without intralipidinfusion.Allpatientswereclosely monitored for any side effectsincluding allergic reactions.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
21 Years 至 42 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • age < 42 years
  • BMI < 30 kg/m2
  • history of 3 or more recurrent implantation failure undergoing Intracytoplasmic Sperm Injection (ICSI ) cycle.
  • exclusion criteria
  • women with medical contraindications of intralipidinfusion.
  • uterine fibroid.
  • endometrial polyp.
  • endometriosis,hydrosalpinx.
  • intrauterine adhesion and uterine anomalies.
  • Women with positive thrombophilia screen.
  • diminished ovarian reserve.
  • severe male factor infertility .
  • chronic medical illnesses which may contribute in impaired chance of pregnancy .

排除标准

  • 未提供

研究组 & 干预措施

treatment group who recived intralipid

Experimental

71 patients who recived intralipid on day of embryo transfer day, pregnancy day.

干预措施: intralipid 20% (Drug)

结局指标

主要结局

pregnancy rate

时间窗: 14 day post embryo transfer day

number of patient with positive b-hcg level 14 day post embryo transfer day.over the study population number in study period.

次要结局

  • miscarrage rate(miscarrage before 20 week gestation)
  • live birth rate(delivery after 28 week gestation)

研究者

申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

jawharah ali alzebidi

fellow

King Fahad Medical City

相似试验